Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis

ClinicalTrials.gov ID: NCT03435081

Public ClinicalTrials.gov record NCT03435081. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 8:52 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the efficacy and safety of baricitinib in adult participants with moderate to severe atopic dermatitis.

Study identification

NCT ID
NCT03435081
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
440 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 20, 2018 (Actual)
Primary completion
Dec 9, 2019 (Actual)
Completion
Aug 16, 2021 (Actual)
Last update posted
Sep 9, 2022

2018 – 2021

United States locations

U.S. sites
60
U.S. states
26
U.S. cities
55
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35233 —
Johnson Dermatology Fort Smith Arkansas 72916 —
Wallace Medical Group, Inc. Beverly Hills California 90211 —
California Dermatology and Clinical Research Institute Encinitas California 92024 —
Tien Q. Nguyen, MD inc. DBA First OC Dermatology Fountain Valley California 92708 —
Center for Dermatology Clinical Research, Inc. Fremont California 94538 —
Keck School of Medicine University of Southern California Los Angeles California 90033 —
University of California Davis-Dermatology Sacramento California 95816 —
Medical Center for Clinical Research San Diego California 92108 —
University Clinical Trials, Inc. San Diego California 92123 —
Southern California Dermatology Santa Ana California 92701 —
Clinical Science Institute Santa Monica California 90404 —
Care Access Research-Walnut Creek Walnut Creek California 94598 —
Clinical Research Center of CT/NY Danbury Connecticut 06810 —
Univ of Connecticut Farmington Connecticut 06032 —
GWU/Medical Faculty Associates Washington D.C. District of Columbia 20037 —
Solutions Through Advanced Research, Inc. Jacksonville Florida 32256 —
Olympian Clinical Research Largo Florida 33770 —
Miami Dermatology & Laser Research Miami Florida 33173 —
Riverchase Dermatology and Cosmetic Surgery Pembroke Pines Florida 33028 —
University of South Florida Tampa Florida 33612 —
ForCare Clinical Research Tampa Florida 33613 —
Dermatologic Surgery Specialists, PC Macon Georgia 31217 —
Advanced Medical Research Sandy Springs Georgia 30328 —
Meridian Clinical Research Savannah Georgia 31406 —
Treasure Valley Dermatology Boise Idaho 83713 —
Northwestern University Chicago Illinois 60611 —
University Dermatology Darien Illinois 60561 —
Arlington Dermatology Rolling Meadows Illinois 60008 —
Dawes Fretzin Clinical Research Indianapolis Indiana 46250 —
The Indiana Clinical Trials Center, PC Plainfield Indiana 46168 —
The South Bend Clinic South Bend Indiana 46617 —
Dermatology Specialist Louisville Kentucky 40241 —
Dermatology and Skin Cancer Specialists Rockville Maryland 20850 —
Tufts Medical Center Boston Massachusetts 02111 —
Brigham and Womens Hospital Boston Massachusetts 02115 —
Great Lakes Research Group, Inc. Bay City Michigan 48706 —
Hamzavi Dermatology Fort Gratiot Michigan 48059 —
Central Dermatology PC St Louis Missouri 63117 —
Skin Specialists, P.C Omaha Nebraska 68144 —
Icahn School of Medicine at Mount Sinai New York New York 10003 —
DermResearchCenter of New York, Inc Stony Brook New York 11790 —
Bexley Dermatology Research Bexley Ohio 43209 —
University Hospitals Cleveland Medical Center Cleveland Ohio 44106 —
Wright State Univ School of Medicine Fairborn Ohio 45324 —
Dermatologists of Southwest Ohio, Inc. Mason Ohio 45040 —
Oregon Dermatology and Research Center Portland Oregon 97210 —
OHSU Center for Health and Healing Portland Oregon 97239 —
Dermatology and Skin Surgery Center Exton Pennsylvania 19341 —
Clinical Partners LLC Johnston Rhode Island 02919 —
Dermatology & Laser Center of Charleston Charleston South Carolina 29407 —
Medical University of South Carolina Charleston South Carolina 29425 —
Bellaire Dermatology Bellaire Texas 77401 —
Modern Research Associates PLLC Dallas Texas 75231 —
Austin Institute for Clinical Research, Inc. Pflugerville Texas 78660 —
Texas Dermatology and Laser Specialists San Antonio Texas 78218 —
Acclaim Dermatology, PLLC Sugar Land Texas 77497 —
University of Utah MidValley Dematology Murray Utah 84107 —
Virginia Clinical Research Norfolk Virginia 23502 —
Multicare Health System Tacoma Washington 98405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 21 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03435081, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 9, 2022 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03435081 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →